Markets » Mutual Funds » Asset Allocation

Reliance Pharma Fund - Direct (G) - Scheme Profile

Fund

Fund House : Reliance Mutual Fund

Fund Class : Equity - Pharma

NAV 22 Jun 2017 131.94 -0.56
(-0.42%)

Asset Type

Asset Allocation
Cash & Cash Equivalent 0.00
CBLO 2.20
Derivatives 0.24
Equity 98.98
Equity Sector No. of Shares Mkt Value % of Assets Stocks Return
Asset / Company Name     (Rs cr)   Last 3 Mths
Aurobindo Pharma Pharmaceuticals - Indian - Bulk Drugs & Fo... 2,050,000 117.70 9.53 -2.21
Divi's Lab. Pharmaceuticals - Indian - Bulk Drugs 2,000,014 116.43 9.43 2.5
Dr Reddy's Labs Pharmaceuticals - Indian - Bulk Drugs & Fo... 450,871 113.79 9.21 0.4
Abbott India Pharmaceuticals - Multinational 270,255 112.91 9.14 -10.03
Cadila Health. Pharmaceuticals - Indian - Bulk Drugs & Fo... 2,300,000 106.74 8.64 17.5
Sanofi India Pharmaceuticals - Multinational 253,207 103.43 8.37 -9.84
› More

Sector Allocation

You can check out the sectoral allocation of the investments made for that scheme by the mutual fund in this Piechart as on the date selected.

Sector Name
Finance & Investments 4.82
Healthcare 4.05
Miscellaneous 5.73
NA 2.44
Pharmaceuticals - Indian - Bulk Drugs 17.70
Pharmaceuticals - Indian - Bulk Drugs & Formln 49.17
Pharmaceuticals - Multinational 17.51

Top Holdings

You can check out the Top Holdings of the investments made for that scheme by the mutual fund in
this Piechart as on the date selected.

Company Name
Abbott India 9.14
Aurobindo Pharma 9.53
Cadila Health. 8.64
Cipla 6.27
Divi's Lab. 9.43
Dr Reddy's Labs 9.21
Glenmark Pharma. 3.28
Health.Global 4.05